PRAX praxismedicines.com Expected net earnings per share growth this year

PRAX (Praxis Corp) - company brandmark

Praxis Precision Medicines (PRAX) is seeing a lack of pricing power due to the testing phase now shift toward monopoly potential. The relative EPS YoY dynamics visualize these expectations, with the 0.00 mark reflecting the current state. Patent protection and high barriers to entry in neuromedicine provide confidence, while operational flexibility is ensured by delegating drug production to reliable contract partners.

PRAX (praxismedicines.com) Earnings per share growth in current year history from 07/04/2022 to 11/16/2026

Financial and market metric breakdowns for Praxis Corp (PRAX)

- current quotes and average value forecast:
Fundamental valuation:PRAX, Praxis Medicines
Manufactured products of Praxis Medicines

This indicator measures the annual dynamics of earnings per share, allowing for the real-time tracking of operating expenses' impact on profitability between reporting periods. Analyzing the proportional growth of EPS compared to last year is critical for Praxis Precision Medicines (PRAX), as it helps assess the extent to which massive clinical R&D expenditures and stringent FDA oversight pressure the company's financial stability.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|AVXL (anavex.com) - Earnings per share increase in current year|CeriBell Inc - Net earnings per share growth this year|PRTA (Prothena Corporation plc) - Earnings per share trend in current year|ALEC - Earnings per share growth in current year|ANNX (Annexon Biosciences Inc.) - Earnings per share growth this year|OMER (omeros.com) - Net earnings per share growth this year|Earnings per share growth this year NGNE|Net earnings per share growth this year ACIU|Earnings growth in current year Voyager Pharma|Net earnings per share growth this year NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth rate in current year|Earnings per share growth in current year Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth rate in current year|CGTX: Net earnings per share growth this year|Inhibikase Therapeutics, Inc. - Net earnings per one share growth for the current year|SAVA: Earnings growth in current year|Earnings per share growth this year ASRT|COYA (coyatherapeutics.com) - Earnings growth in current year|Vistagen (VTGN) - Expected net earnings per share growth this year|Net earnings per share growth this year OVID (Ovid Rx)|Expected net earnings per share growth this year Acumen Pharmaceuticals, Inc.|Earnings growth in current year CRVO (CervoMed Corporation)|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Earnings growth in current year|Net earnings per share change in current year pepgen.com (PEPG)|JUNS: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE